New hope for hepatitis b? early trial of Tune-401 begins
Disease control
Recruiting now
This early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral medication. The goal is to see if Tune-401 is safe and how the body processes it, not yet to cure the infection.
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC